October 18, 2018
Glenmark Pharmaceuticals Inc. has asked a Virginia federal judge to nix a suit accusing it of conspiring with Merck & Co. to delay production of a competitor to Merck's cholesterol treatment Zetia, saying that a private settlement with Merck did not prevent the launch of lower-priced alternatives.
April 02, 2018
Merck & Co. urged a Virginia federal judge on Monday to ax allegations it conspired with generics manufacturer Glenmark Pharmaceuticals Inc. to delay production of a competitor to cholesterol treatment Zetia, saying the suit is subject to an arbitration clause in the company's distribution agreement.
January 17, 2018
Merck & Co. and generics manufacturer Glenmark Pharmaceuticals Inc. were hit with a putative class action in Virginia federal court Wednesday claiming an agreement to keep a generic version of cholesterol treatment Zetia off the market for five years created an unlawful monopoly.